Sarah Ketterer - Causeway Capital Management
Holding/activity history for GSK plc (GSK)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026 Q1 | 11,110 | 0.01 | Reduce 67.22% | 0.01 | $55.19 | $613,177 | SEC |
| 2025 Q4 | 33,897 | 0.02 | Reduce 97.12% | 0.65 | $49.04 | $1,662,321 | SEC |
| 2025 Q3 | 1,177,001 | 0.67 | Add 6.32% | 0.04 | $43.16 | $50,799,344 | SEC |
| 2025 Q2 | 1,107,076 | 0.67 | Reduce 0.08% | <0.01 | $38.40 | $42,511,705 | SEC |
| 2025 Q1 | 1,107,923 | 0.90 | Add 2.91% | 0.03 | $38.74 | $42,920,943 | SEC |
| 2024 Q4 | 1,076,580 | 0.83 | Add 19.97% | 0.14 | $33.82 | $36,409,929 | SEC |
| 2024 Q3 | 897,406 | 0.90 | Add 19.09% | 0.14 | $40.88 | $36,685,942 | SEC |
| 2024 Q2 | 753,535 | 0.79 | Add 2.22% | 0.02 | $38.50 | $29,011,113 | SEC |
| 2024 Q1 | 737,185 | 0.83 | Reduce 7.32% | 0.05 | $42.87 | $31,603,132 | SEC |
| 2023 Q4 | 795,441 | 0.75 | Add 40.85% | 0.22 | $37.06 | $29,479,046 | SEC |
| 2023 Q3 | 564,747 | 0.54 | Add 41.39% | 0.16 | $36.25 | $20,472,082 | SEC |
| 2023 Q2 | 399,430 | 0.37 | Add 25.15% | 0.07 | $35.64 | $14,235,678 | SEC |
| 2023 Q1 | 319,160 | 0.27 | Add 34.65% | 0.07 | $35.58 | $11,355,718 | SEC |
| 2022 Q4 | 237,033 | 0.24 | Add 29.14% | 0.05 | $35.14 | $8,329,323 | SEC |
| 2022 Q3 | 183,544 | 0.15 | Reduce 28.90% | 0.08 | $29.43 | $5,402,000 | SEC |
| 2022 Q2 | 258,163 | 0.28 | Buy | 0.28 | $43.53 | $11,238,000 | SEC |